These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 20036936

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Chemokines and angiogenesis in rheumatoid arthritis.
    Szekanecz Z, Pakozdi A, Szentpetery A, Besenyei T, Koch AE.
    Front Biosci (Elite Ed); 2009 Jun 01; 1(1):44-51. PubMed ID: 19482623
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. New drug targets in rheumatoid arthritis: focus on chemokines.
    Shadidi KR.
    BioDrugs; 2004 Jun 01; 18(3):181-7. PubMed ID: 15161335
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Chemokines and their receptors in rheumatoid arthritis: future targets?
    Koch AE.
    Arthritis Rheum; 2005 Mar 01; 52(3):710-21. PubMed ID: 15751074
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Chemokine and chemokine receptor blockade in arthritis, a prototype of immune-mediated inflammatory diseases.
    Szekanecz Z, Koch AE, Tak PP.
    Neth J Med; 2011 Sep 01; 69(9):356-66. PubMed ID: 21978977
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus.
    Henneken M, Dörner T, Burmester GR, Berek C.
    Arthritis Res Ther; 2005 Sep 01; 7(5):R1001-13. PubMed ID: 16207316
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Synovial lymphoid neogenetic factors in Behçet's synovitis: do they play a role in self-limiting and subacute course of arthritis?
    Pay S, Musabak U, Simsek I, Erdem H, Pekel A, Sengul A, Dinc A.
    Clin Exp Rheumatol; 2007 Sep 01; 25(4 Suppl 45):S21-6. PubMed ID: 17949547
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Increased IL-17 production by peripheral T helper cells after tumour necrosis factor blockade in rheumatoid arthritis is accompanied by inhibition of migration-associated chemokine receptor expression.
    Aerts NE, De Knop KJ, Leysen J, Ebo DG, Bridts CH, Weyler JJ, Stevens WJ, De Clerck LS.
    Rheumatology (Oxford); 2010 Dec 01; 49(12):2264-72. PubMed ID: 20724433
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.